{"id":49931,"date":"2012-07-22T07:18:47","date_gmt":"2012-07-22T07:18:47","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/wests-first-gene-therapy-gets-closer-to-market.php"},"modified":"2012-07-22T07:18:47","modified_gmt":"2012-07-22T07:18:47","slug":"wests-first-gene-therapy-gets-closer-to-market","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/wests-first-gene-therapy-gets-closer-to-market.php","title":{"rendered":"West&#39;s first gene therapy gets closer to market"},"content":{"rendered":"<p>Rare illness treatment Glybera wins European drugs regulator&#39;s approval in &#39;watershed moment&#39; The first gene therapy to treat a rare illness came closer to market today after the European drugs regulator recommended the medicine for approval across member states. The therapy, Glybera , is for patients with an unusual genetic disorder that means their bodies fail to make an enzyme that breaks ...<\/p>\n<p>See the original post here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.guardian.co.uk\/science\/2012\/jul\/20\/west-first-gene-therapy-market\" title=\"West&#39;s first gene therapy gets closer to market\">West&#39;s first gene therapy gets closer to market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rare illness treatment Glybera wins European drugs regulator&#39;s approval in &#39;watershed moment&#39; The first gene therapy to treat a rare illness came closer to market today after the European drugs regulator recommended the medicine for approval across member states. The therapy, Glybera , is for patients with an unusual genetic disorder that means their bodies fail to make an enzyme that breaks ... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/wests-first-gene-therapy-gets-closer-to-market.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-49931","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/49931"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=49931"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/49931\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=49931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=49931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=49931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}